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Abstract
Background: We present the design of an open randomized multi-centre study on surgical versus
conservative treatment of acute Achilles tendon ruptures. The study is designed to evaluate the
effectiveness of conservative treatment in reducing complications when treating acute Achilles
tendon rupture.
Methods/Design: At least 72 patients with acute Achilles tendon rupture will be randomized to
minimally invasive surgical repair followed by functional rehabilitation using tape bandage or
conservative treatment followed by functional rehabilitation with use of a functional bracing system.
Both treatment arms use a 7 weeks post-rupture rehabilitation protocol. Four hospitals in the
Netherlands will participate. Primary end-point will be reduction in complications other than re-
rupture. Secondary end-point will be re-rupturing, time off work, sporting activity post rupture,
functional outcome by Leppilahti score and patient satisfaction. Patient follow-up will be 12 month.
Discussion: By making this design study we wish to contribute to more profound research on AT
rupture treatment and prevent publication bias for this open-labelled randomized trial.
Trial registration: ISRCTN50141196
Background
Controversy continues with regard to the optimal treat-
ment for acute subcutaneous Achilles tendon (AT) rup-
tures. Treatment can be classified into operative (open or
minimally invasive/percutaneous) and non-operative.
Post operative splintage can be divided into cast immobi-
lisation and functional bracing.
Traditionally open surgical repair of a ruptured Achilles
tendon has been the first choice of treatment due to low
re-rupture rates and the possibility for functional post-
operative splintage [1-4]. But, 34% of patients treated
with open repair suffer from complications other than re-
rupture, especially wound infection and adhesions [1-5].
In general, the outcome after treatment of a re-rupture is
poor, but results following treatment of a deep infection
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are devastating [6]. Therefore an effort should be made to
prevent infectious complications. Many articles on differ-
ent types of minimally invasive repair techniques (using
limited incisions or performed percutaneously) of rup-
tured AT's have been published [7-14]. But to date, only
two 2 randomized trials have been reported [4,15]. In
Khan's review on randomized trials complications other
than re-rupture were substantially reduced with percuta-
neous repair techniques but data were very limited. Data
on complications using limited incision techniques are
even more scant. As minimally invasive techniques differ
it is hard to compare other techniques with these num-
bers. An advantage of most minimally invasive techniques
is smaller scars and less damage to the delicate blood sup-
ply of the AT. Importantly, in most patients minimally
invasive surgery does allow functional rehabilitation [7].
Patients treated by functional rehabilitation after opera-
tion rather than cast immobilisation are reported to have
a shorter in-patient stay, less time off work and a quicker
return to sporting activities. In addition, lower complica-
tion rates, including re-ruptures, are reported [1-5].
The main advantage of conservative, i.e. non-operative
treatment is elimination of wound complications and
intra-operative sural nerve damage. Complications other
than re-rupture are reported to reduce to 3% [5]. But, con-
servative treatment with cast immobilisation has shown
to increase the re-rupture rate [1,5] and cast immobilisa-
tion induces delayed recovery due to calf muscle weakness
as a result of long immobilisation of the ankle joint. In
contrast, conservative treatment by functional bracing
does allow immediate weight bearing, preventing calf
muscle weakness and enabling fast recovery. In three stud-
ies conservative treatment of AT rupture with functional
bracing did not result in increased re-rupture rates [16-
18]. But since only one of these is a randomized trial [17],
more high quality data from randomized prospective
studies is needed. We hypothesized that compared to sur-
gical treatment, conservative treatment with functional
bracing will reduce the absolute risk of complications
other than re-rupture with 30%.
Methods/Design
Design of study
Context
The efficacy of minimally-invasive surgery versus func-
tional conservative treatment of acute subcutaneous
Achilles tendon ruptures will be studied in a randomized
trial. Four hospitals in the Netherlands will participate in
the study, one of them being a university medical centre.
The Medical Research Ethics Committee of all the partici-
pating hospitals approved the study protocol.
Patient selection and informed consent
All patients who report to the emergency department of
one of the participating hospitals with an acute Achilles
tendon rupture will be considered for entering the study
protocol. Inclusion and exclusion criteria are listed in
table 1 and will be checked by an emergency room doctor,
surgical resident or surgeon. All eligible patients are asked
to provide written informed consent.
Randomisation and concealment
Randomisation is concealed by a specially designed inter-
net site. Randomisation is in blocks (4 blocks) and strati-
fied by centre. The treatment nature is open labelled for
patients, physicians and physiotherapists. During follow-
up visits physical examination reveals the allocated treat-
ment to patient and assessor.
Interventions
Surgical therapy consists of a minimally invasive tech-
nique (Figure 1) [7]. The same protocol for the operative
procedure was used by all surgeons and residents in the
participating hospitals. Also, before study participation all
surgeons were familiar with the operative procedure. A
less than 5 cm longitudinal incision is made over the pos-
terior aspect of the affected leg just proximal to the rupture
site. The incision is slightly medially placed. The subcuta-
neous fat is divided and the peritendineum opened. Then
a Bunell type suture is placed though the proximal end of
the Achilles tendon (PDS 1.0). With a hollow mandarin
the suture is tunnelled to the lateral aspect of the calcaneal
bone and guided out through a 5 mm stab incision. A hole
is drilled through the calcaneal bone 1 cm distal to the
tendon insertion (exit through 5 mm stab incision medi-
Table 1: Inclusion and exclusion criteria
Inclusion Criteria Exclusion criteria
Achilles tendon rupture. Re-rupture/bilateral rupture/open rupture.
Treatment starts within 72 hours. Combination with fracture of foot or ankle.
Diagnoses by physical examination: palpable gap and calf muscle squeeze 
test.
Former application (injection) of local corticosteroids in tendon area.
Age 18–65 years. Contra-indications for surgery.
Written informed consent. Physical or mental handicaps that do not allow functional treatment or 
otherwise interfere with the ability to follow-up on the study protocol.BMC Musculoskeletal Disorders 2007, 8:108 http://www.biomedcentral.com/1471-2474/8/108
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ally). The PDS in guided though the hole. Now the man-
darin is used to guide the suture back to the proximal site
of the tendon. After the foot is placed in plantar flexion
the suture is tied. After wound closure a cast is applied
with the foot still in plantar flexion. After one week a tape
bandage is applied for a total period of 6 weeks. In the first
two weeks the tape bandage is supported by a 2 cm heel
raise. The following 2 weeks the heel raise is reduced to 1
cm. The last two weeks the heel raise is removed (tape
bandage will be renewed every time the heel raise is
changed). Full weight bearing is allowed during the 6
weeks of tape bandage, not allowing sporting activities or
walking stairs on tiptoes. Crutches are advised in the first
week of casting, thereafter for maintenance of balance, but
only if necessary.
Conservative therapy consists of a cast in plantar flexion
for one week. After one week a functional bracing system
(Vacoped, Figure 2) [19] is applied for 6 weeks. The
Vacoped bracing system (Company OPED, Valley, Ger-
many) is a multifunctional splint consisting of several
components. The essential parts are the dorsal and ventral
shell, the vacuum cushion with changeable terry cloth
covers, the belts with security locks and the removable
sole. Prior to study use the brace was successfully used in
a small pilot series and an instructions meeting on brace
application was held in all participating hospitals. In the
first two weeks the brace is fixed in 30° plantar flexion.
The following 2 weeks in is in rigid 15° plantar flexion.
The last two weeks the brace is dynamic from neutral posi-
tion to 30° plantar flexion. Full weight bearing is allowed
during the 6 weeks of bracing, not allowing sporting activ-
ities or walking stairs on tiptoes. Crutches are advised in
the first week of casting, thereafter for maintenance of bal-
ance, but only if necessary.
After tape or brace removal patients were advised further
rehabilitation with physiotherapist and were allowed
sports 3 months after rupture. Patients were free to choose
their physiotherapist.
Design of collection of data
Primary endpoint
complications other than re-rupture, i.e. infection, dis-
turbed wound healing, sural nerve injury, scar adhesions,
deep vein thrombosis and all other complications per
treatment group.
Surgical repair technique Figure 1
Surgical repair technique. Taken from [7].
Vacoped Figure 2
Vacoped.BMC Musculoskeletal Disorders 2007, 8:108 http://www.biomedcentral.com/1471-2474/8/108
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During follow-up all complications will be documented
by a surgeon or resident according to a standardised pro-
cedure using the definitions of complications presented in
the Table 2. All complications will be included in the final
analysis of results.
Secondary endpoint
re-rupturing (clinical diagnosis supported by ultrasound),
time off work, sporting activity post rupture and patient
satisfaction. The Thompson test is used for clinical diag-
nosis of re-rupture. Failure in plantar movement of the
foot during calf muscle squeeze is considered a positive
sign for re-rupture. Ultrasound evaluation for re-rupture is
performed in neutral ankle position. Complete tendon
rupture with tendon gap was considered a re-rupture.
Time off work will be registered by a patient diary. Com-
plete return to profession was used as endpoint. Stratifica-
tion to type of profession (sedentary and non-sedentary)
will be performed afterwards. A visual analogue scale
(VAS) on patient satisfaction with treatment will be meas-
ured at 7 weeks, 3 and 12 month. Patient outcome will
also be evaluated by the Leppilahti scoring method, a clin-
ical scoring system, including subjective assessment of
symptoms and evaluation of ankle range of motion and
isokinetic measurement of ankle plantar flexion and dor-
sifexion strengths (Table 3) [20].
Follow-up
Follow-up visits for assessment of primary and secondary
endpoints will be scheduled every week during the first 7
weeks. Thereafter, follow-up visits will be planned at 3, 6
and 12 month. Any other consultation for complaints
concerning the Achilles tendon area will be documented.
Design of analysis
Results will be analysed according the intention tot treat
principle.
Data analysis
The study groups will be compared for their baseline char-
acteristics. The number of complications will be calcu-
lated for the primary endpoint. Distribution measures will
be calculated for the secondary endpoints at the different
moments of follow-up. Differences between groups for
the number of complications and distribution of other
endpoints will be calculated for each outcome measure
with a 95% confidence interval. The study groups will be
compared with the chi-square test for categorical outcome
variables and the independent sample Student t test for
continuous outcome variables. The dropouts and with-
drawals will be summarized and analyzed by treatment
groups. A listing of subject with withdrawal with the date
and reasons for termination will be provided.
Because we standardised the intevention procedures we
do not anticipate important differences between centers.
So we do not stratify our primary analysis for center. How-
ever, when eventually differences may occur we will
explore their effect in a secondary analysis (Mantel-Haen-
szel). All analysis in SPSS (SPSS Inc, Chicago Illinois).
Sample size
Sample size is calculated on the basis of complication
other than re-rupture. With conservative treatment using
this new type of functional bracing we hypothesized a
30% reduction in the absolute risk for complications
other than re-rupture. This risk reduction is similar to the
risk reduction obtained in the systematic review on open
versus conservative treatment by Khan: risk of complica-
tions for open repair being 34% [5]. Prospective data on
the risk of complications of minimally invasive repair is
very scant. The Khan review provides the best empirical
estimate for the complication risk associated with surgical
repair. Therefore we decided to use this risk estimate of
complications of open repair for the sample size calcula-
tion. With a one-sided α of 0.05, a statistical power of (1-
β) of 0.80, and an attrition rate of 10% we need to rand-
omize at least 36 patients per treatment arm.
Discussion
This study is primarily designed to evaluate the effective-
ness of conservative treatment of acute AT ruptures, using
a functional bracing system, in reducing complications
other than re-rupture. A comparison is made between this
functional bracing system and a minimally invasive oper-
ative repair of acute AT ruptures. Both treatment options
Table 2: Definitions of complications used during follow-up.
Complication Definition
Infection Clinical signs of wound infection, i.e. redness, swelling, pain and functional impairment. Deep infection is defined as an 
infection beyond skin or subcutaneous fat needing surgical treatment in the operating theatre.
Disturbed wound healing Keloid formation or hypertrophic scar, secondary wound healing, protruding PDS knot.
Sural nerve injury Any sign of altered sensibility in the sural nerve area diagnosed by surgeon or surgical resident (using touch and pin prick 
test).
Scar adhesion Clinical signs of adhesion of skin to underlying tissue layers. Clear wound retraction at ankle movement.
Deep vein thrombosis Clinical and ultrasonographic signs of deep vein thrombosis of the ipsilateral lower leg.
Other complications Any complication met during follow-up.BMC Musculoskeletal Disorders 2007, 8:108 http://www.biomedcentral.com/1471-2474/8/108
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used in this comparison allow immediate full weight
bearing so none of the patients is denied the purported
advantage of a functional after treatment [2,5,21-24].
There have been randomized clinical trials on treatment
of acute Achilles tendon rupture but the methodological
rigour is often low. There is a need for more rigorous
designed studies on AT rupture treatment as this subject is
still very much under debate. By publishing our protocol
we wish to show our care for a profound design and meth-
odological quality of our protocol. Moreover, when the
design of a study is published it will help to achieve trans-
parency about why and how studies are undertaken. The
publication of a study design may help to reduce the prob-
lem of publication bias, i.e. selective publication of posi-
tive associations and disregarding negative and weak
associations, prevent unnecessary duplication of research
efforts and duplicate publication [25]. To our knowledge,
there has never been a design study published regarding
treatment of AT ruptures. By making this design study we
wish to contribute to more profound research on AT rup-
ture treatment and prevent publication bias for this open-
labelled randomized trial.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Table 3: Leppilahti score.
Clinical factors Scores (points)*
Pain
None 15
Mild, no limitations on recreational activities 10
Moderate, limitations on recreational, but not daily activities 5
Severe, limitations on recreational and daily activities 0
Stiffness
None 15
Mild, occasional, no limitations on recreational activities 10
Moderate, limitations on recreational, but not daily activities 5
Severe, limitations on recreational and daily activities 0
Calf muscle weakness (subjective)
None 15
Mild, no limitations on recreational activities 10
Moderate, limitations on recreational, but not daily activities 5
Severe, limitations on recreational and daily activities 0
Footwear restrictions
None 10
Mild, most shoes tolerated 5
Moderate, unable to tolerate fashionable shoes, modified shoes tolerated 0
Active range of motion (ROM) difference between ankles
Normal (<6°) 15
Mild (6°–10°) 10
Moderate (11°–15°) 5
Severe (>15°) 0
Subjective result
Very satisfied 15
Satisfied with minor reservations 10
Satisfied with major reservations 5
dissatisfied 0
Isokinetic muscle strength (score)
Excellent 15
Good 10
Fair 5
poor 0
* Maximum overall score 100. An overall score of 90–100 rates excellent, 75–85 is good, 60–70 is fair and <55 is poor.Publish with BioMed Central    and   every 
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